European Medical Device Investigator Initiated Study Conference

Maximizing Medical Device Investigator Initiated Research through Effective Management of Investigators & Studies, Training on Policies, Procedures & Regulations, all within a Unclear Regulatory Framework in Europe

April 23-24, 2012 | Berlin, Germany

 

ABOUT THE CONFERENCE

 

Throughout the medical device industry, manufacturers are struggling with the volume of requests from investigators who are interested in conducting research studies on new and existing products. While these studies were traditionally only led by a select number of key opinion leaders, many doctors and physicians in Europe are now considering these types of studies as a way to advance not only medical technology, but also their own profiles as industry experts. Executives in Medical and Clinical Affairs need to be prepared with strategies and policies which will govern how to best handle these types of research; especially given the rapidly evolving regulatory environment.

Throughout the program, interactive sessions will enable professionals to engage in a lively debate and discussion on the challenges and opportunities that investigator initiated research presents to today's global medical device corporation. As with all Q1 programs, the strictly controlled attendance will minimize participation of outside consultants, providing attendees with an atmosphere focused on knowledge share, learning and networking; ideal for those consultants and solution providing companies looking to enter this exciting market.



| Read More |


TOPICS TO INCLUDE:

 

  • Establishing a Common Terminology Framework: Defining "Sponsors," and Other Challenges
  • Aligning External Studies with Corporate Medical Strategy
  • Determining the Best Approach for Each Investigator Initiated Study
  • Identifying Which IIS to Support for Maximized Return on Investment
  • Developing a Cohesive Investigator Initiated Study Contract
  • Obtaining & Securing IP Protection When Conducting External Research Studies in the EU, Focus On Germany
  • Establishing Clear Study Protocols with External Investigators
  • Strategies for Engaging With Physicians in Investigator Initiated Research
  • Best Practices: Achieving Better Collaboration by Training External Investigators
  • ISO 14155 Revision: Clarifying New Requirements with Investigators
  • Opportunities in the Internal Management of Device Investigator Initiated Studies
  • Overcoming Hurdles in Funding Of an IIS & Fair Market Value
  • Ensuring Financial Disclosure in Investigator Initiated Studies
  • Overcoming Challenges in Turning Away Studies While Maintaining Physician Relationships
  • Learning Opportunities from the Pharmaceutical Industry's Experience in IIS
  • Successful Insurance Planning In Investigator Initiated Studies

| And More |

 

registernow

 

FWD to a Colleague


Add to Calendar


 

 

 

KEY PRESENTERS TO INCLUDE:

 

Peter Bannister
Chief Scientific Officer
Eykona Technologies

 

Luc Verhees
Medical Affairs Director, Europe
Medtronic

 

Katrin Leadley
Chief Medical Officer
Jenavalve

 

| And More |

 

Contact: Paul Hernandez | Marketing Director | 312.602.9683 | phernandez@q1productions.com

 

Mailing List Sign-Up